147 related articles for article (PubMed ID: 1716279)
1. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
Johns LD; Flanders KC; Ranges GE; Sriram S
J Immunol; 1991 Sep; 147(6):1792-6. PubMed ID: 1716279
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
Racke MK; Dhib-Jalbut S; Cannella B; Albert PS; Raine CS; McFarlin DE
J Immunol; 1991 May; 146(9):3012-7. PubMed ID: 1707929
[TBL] [Abstract][Full Text] [Related]
3. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor.
Santambrogio L; Hochwald GM; Saxena B; Leu CH; Martz JE; Carlino JA; Ruddle NH; Palladino MA; Gold LI; Thorbecke GJ
J Immunol; 1993 Jul; 151(2):1116-27. PubMed ID: 8335893
[TBL] [Abstract][Full Text] [Related]
5. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
6. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
[TBL] [Abstract][Full Text] [Related]
7. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
[TBL] [Abstract][Full Text] [Related]
8. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
Santos LM; al-Sabbagh A; Londono A; Weiner HL
Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838
[TBL] [Abstract][Full Text] [Related]
9. Demyelination induced by T cell lines and clones specific for myelin basic protein in mice.
Tabira T; Sakai K
Lab Invest; 1987 May; 56(5):518-25. PubMed ID: 2437389
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis.
Kiefer R; Gold R; Gehrmann J; Lindholm D; Wekerle H; Kreutzberg GW
J Neurosci Res; 1993 Nov; 36(4):391-8. PubMed ID: 7505838
[TBL] [Abstract][Full Text] [Related]
11. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis.
Weinberg AD; Whitham R; Swain SL; Morrison WJ; Wyrick G; Hoy C; Vandenbark AA; Offner H
J Immunol; 1992 Apr; 148(7):2109-17. PubMed ID: 1347550
[TBL] [Abstract][Full Text] [Related]
13. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
Racke MK; Burnett D; Pak SH; Albert PS; Cannella B; Raine CS; McFarlin DE; Scott DE
J Immunol; 1995 Jan; 154(1):450-8. PubMed ID: 7527821
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
[TBL] [Abstract][Full Text] [Related]
15. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
[TBL] [Abstract][Full Text] [Related]
16. Presence of T cells with activated and memory phenotypes in inflammatory spinal cord lesions.
Barten DM; Clark RB; Ruddle NH
J Immunol; 1995 Dec; 155(11):5409-18. PubMed ID: 7594558
[TBL] [Abstract][Full Text] [Related]
17. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
Chen Y; Inobe J; Weiner HL
J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance.
Tan LJ; Kennedy MK; Dal Canto MC; Miller SD
J Immunol; 1991 Sep; 147(6):1797-802. PubMed ID: 1716280
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
Selmaj K; Raine CS; Cross AH
Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
